Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
Emory University
Gruppo Italiano Malattie EMatologiche dell'Adulto
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
University of California, Davis
Mayo Clinic
University of Michigan Rogel Cancer Center
City of Hope Medical Center
Technical University of Munich